首页 | 本学科首页   官方微博 | 高级检索  
     


Clinicopathological study of proliferating cell nuclear antigen (PCNA) of hepatocytes in primary biliary cirrhosis
Authors:Minoru Shibata  Masashi Watanabe  Yukihisa Ueno  Takaaki Sadamoto  Genichiro Sato  Tatuo Yasushi  Tomoyuki Yamagami  Shirou Tuzimoto  Makoto Enomoto
Affiliation:1. Department of Internal Medicine, Kawasaki Central Hospital, Tamachi 2-9-1 Kawasaki-ku, Kawasakishi, 210, Kanagawa, Japan
2. First Department of Surgery, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, 143, Tokyo, Japan
3. Department of Surgery, Kawasaki Central Hospital, Tamachi 2-9-1, Kawasaki-ku, Kawasakishi, 210, Kanagawa, Japan
4. Department of Pathology, Kawasaki Central Hospital, Tamachi 2-9-1, Kawasaki-ku, Kawasakishi, 210, Kanagawa, Japan
5. Department of Pathology, Biosafety Research Center, Food, Drugs and Pesticides, 582-2 Aza Arahama Shioshinden, Fukude-machi, Iwata-gun, 437-12, Shizuoka, Japan
Abstract:The DNA synthesis activities of hepatocytes in primary biliary cirrhosis (PBC) and other chronic liver diseases and control subjects were examined by staining proliferating cell nuclear antigen (PCNA) with anti-PCNA monoclonal antibody. The number of PCNA-positive cells (PCNA value) was significantly higher in PBC (375±281 parts per thousand; ppt) than in other chronic liver diseases, i.e., chronic hepatitis (95±83 ppt), liver cirrhosis (72±71 ppt), and alcoholic liver disease (73±56 ppt), and in control subjects (11±14 ppt). The PCNA value of PBC in stages I-III of Scheuer's classification was remarkably high, while in stage IV it was low. Even in identical, Scheuer's stages, the PCNA value of PBC was higher in patients who were not given ursodeoxycholic acid (UDCA) than in those who received UDCA. In identical patients, the PCNA value was lowered significantly after UDCA treatment. It was concluded that the DNA synthesis activity of PBC in stages I-III was accelerated and that UDCA can alleviate the abnormality in DNA synthesis activity.
Keywords:proliferating cell nuclear antigen  primary biliary cirrhosis  ursodeoxycholic acid
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号